CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit | −1,363 | 1,364 | ||
| 2023-12-13 | HEALY JAMES Director | Sale | −644,000 | $58.75 | $37.8M | 0 |
| 2023-12-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Gift | +250,000 | 670,000 | ||
| 2023-12-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Gift | −250,000 | 1,003,580 | ||
| 2023-12-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Gift · Stock Option (right to buy) | −380,036 | 0 | ||
| 2023-12-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Gift · Stock Option (right to buy) | +380,036 | 380,036 | ||
| 2023-12-08 | Marcus Gail Boxer Director | Sale | −500 | $57.52 | $29K | 20,146 |
| 2023-12-06 | Sheena Jonathan Director | Sale 10b5-1 | −4,600 | $58.16 | $268K | 475,143 |
| 2023-12-06 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $58.88 | $24K | 474,743 |
| 2023-11-29 | Chapman Rowan E Director | Sale | −1,998 | $55.97 | $112K | 9,373 |
| 2023-11-21 | Marcus Gail Boxer Director | Sale | −1,000 | $54.31 | $54K | 20,646 |
| 2023-11-20 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,566 | $55.00 | $141K | 217,554 |
| 2023-11-02 | Sheena Jonathan Director | Sale 10b5-1 | −5,000 | $40.23 | $201K | 479,743 |
| 2023-11-02 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $40.47 | $20K | 22,155 |
| 2023-11-02 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $40.23 | $20K | 22,155 |
| 2023-10-27 | Williams Brinkley Ruth Director | Grant or award · Stock Option (right to buy) | +515 | $25.03 | $13K | 515 |
| 2023-10-27 | BOTHA ROELOF Director | Grant or award · Stock Option (right to buy) | +807 | $25.03 | $20K | 807 |
| 2023-10-27 | ROSENMAN HERM Director | Grant or award | +454 | $42.60 | $19K | 61,382 |
| 2023-10-27 | HEALY JAMES Director | Grant or award | +396 | $42.60 | $17K | 42,236 |
| 2023-03-29 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Gift | +613,496 | 1,253,580 |
Page 84 of 85 · 1,682 trades